Acarbose attenuates experimental non-alcoholic steatohepatitis.
D020909:Acarbose / Q000494:pharmacology*; D000818:Animals; D003094:Collagen / Q000096:biosynthesis; D019392:Cytochrome P-450 CYP2E1 / Q000096:biosynthesis; D004041:Dietary Fats / Q000008:administration & dosage; D004195:Disease Models, Animal; D005234:Fatty Liver / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism / Q000473:pathology; D006520:Hepatitis, Animal / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism / Q000473:pathology; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D008099:Liver / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D008297:Male; D012333:RNA, Messenger / Q000096:biosynthesis; D051381:Rats; D017207:Rats, Sprague-Dawley; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis
D004041:Dietary Fats; D007004:Hypoglycemic Agents; D012333:RNA, Messenger; D014409:Tumor Necrosis Factor-alpha; D003094:Collagen; D019392:Cytochrome P-450 CYP2E1; D020909:Acarbose